News Technology Predictive Risk Models Ethics, Regulation, and Responsible Use Diagnostics & Imaging

How to build infographics with AI

June 10, 2026 By AACE Endocrine AI staff 1 min watch
Share Share via Email Share on Facebook Share on LinkedIn Share on Twitter

If you're interested in using AI to create educational materials but don't know where to start, we can help. This video demonstrates how you can create your own endocrinology-focused clinical infographics with AI tools such as easy-peasy.ai.

In this example, which was created by Johnson Thomas, MD, FACE, FEAA, Section Chair of Endocrinology at Mercy Hospital Springfield in Missouri and Editor-in-Chief of AACE Endocrine AI, the infograph is titled "Osteoporosis: Screening, Treatment & Monitoring." Dr. Thomas directs the prompt to compare outputs from ChatGPT, Claude, and Gemini, showing how the same detailed prompt can produce different infographic styles, levels of detail, and clinical usability. The video emphasizes three practical lessons:

 

  • Write specific prompts,

  • Provide a visual template when possible, and

  • Verify all clinical information against current guidelines before sharing.

For practicing endocrinologists, AI tools can help translate complex clinical topics—such as DXA screening, thyroid cancer risk, monitoring intervals, etc. —into clearer patient- or clinician-facing educational materials. Of course, it's vital to remember the foundation of responsibile AI use when creating infographics and other educational materials: AI can speed up content creation, but endocrinologists still need to guide the prompt, evaluate readability and accuracy, and ensure the final output supports—not replaces—clinical judgment.


Infographics Prompt


If you didn't catch the prompt in the video, here is how to create the same osteoporosis infographic.


Prompt: Create a single-page medical infographic on "Osteoporosis: Screening, Treatment & Monitoring."


Template adherence (highest priority): I am attaching a template image. Replicate its style, and overall visual structure.


Format: One page, square (1080×1080) or 4:5 portrait, optimized for sharing on X (legible when viewed on a phone, high contrast, no text smaller than would be readable at thumbnail scale). No content cut off at edges; safe margins on all sides.


Title: "Osteoporosis: Screening to Monitoring" with a clean clinical subtitle.


Content sections (populate the template with these):


1. Screening Test: Central DXA (dual-energy X-ray absorptiometry) of hip and spine is the standard; report T-scores. Note: T-score ≤ −2.5 = osteoporosis; −1.0 to −2.5 = osteopenia/low bone mass. FRAX may be used to estimate fracture risk. Baseline bone turnover markers (BTMs) can be checked before starting therapy.


2. When to Screen: Women ≥ 65 and men ≥ 70; younger postmenopausal women and men 50–69 with risk factors (prior fragility fracture, glucocorticoid use, low body weight, parental hip fracture, smoking, excess alcohol, secondary causes). Screen anyone with a fragility fracture.


3. Treatment Options & Categories (two categories):


Antiresorptive: bisphosphonates (alendronate, risedronate, zoledronic acid), denosumab, and estrogen/SERMs (raloxifene).


Anabolic: teriparatide, abaloparatide, and romosozumab (dual action). Plus universal foundation: calcium, vitamin D, weight-bearing exercise, fall prevention.


4. Bone Turnover Markers (BTMs): Blood/urine markers reflecting bone remodeling, useful for assessing treatment response and adherence (often faster feedback than DXA).


Resorption marker: serum CTX (C-terminal telopeptide) — falls with antiresorptive therapy.


Formation marker: serum P1NP (procollagen type 1 N-propeptide) — rises with anabolic therapy.


Check baseline, then recheck ~3 months after starting/changing therapy to confirm response.


5. Monitoring: Repeat DXA typically every 2 years to assess response; use BTMs (CTX/P1NP) for earlier feedback on response and adherence; reassess fracture risk and "drug holiday" eligibility for bisphosphonates over time.


Visual style: Calm clinical palette (blues/teals with one accent), clear icons per section, strong visual hierarchy, no decorative clutter.


Footer line (required): "Educational use only — verify against current guidelines. Not a substitute for clinical judgment."


Output: A single high-resolution image faithfully matching the attached template.

Related Content